These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 22240838)

  • 1. Long-lasting inhibitory effects of cyclosporin A, but not tacrolimus, on OATP1B1- and OATP1B3-mediated uptake.
    Shitara Y; Takeuchi K; Nagamatsu Y; Wada S; Sugiyama Y; Horie T
    Drug Metab Pharmacokinet; 2012; 27(4):368-78. PubMed ID: 22240838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-incubation with OATP1B1 and OATP1B3 inhibitors potentiates inhibitory effects in physiologically relevant sandwich-cultured primary human hepatocytes.
    Farasyn T; Pahwa S; Xu C; Yue W
    Eur J Pharm Sci; 2021 Oct; 165():105951. PubMed ID: 34311070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver.
    Sato T; Yamaguchi H; Kogawa T; Abe T; Mano N
    J Pharm Pharm Sci; 2014; 17(4):475-84. PubMed ID: 25579430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-drug interaction between pitavastatin and various drugs via OATP1B1.
    Hirano M; Maeda K; Shitara Y; Sugiyama Y
    Drug Metab Dispos; 2006 Jul; 34(7):1229-36. PubMed ID: 16595711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans.
    Ishiguro N; Maeda K; Kishimoto W; Saito A; Harada A; Ebner T; Roth W; Igarashi T; Sugiyama Y
    Drug Metab Dispos; 2006 Jul; 34(7):1109-15. PubMed ID: 16611857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.
    Noé J; Portmann R; Brun ME; Funk C
    Drug Metab Dispos; 2007 Aug; 35(8):1308-14. PubMed ID: 17470528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil.
    Treiber A; Schneiter R; Häusler S; Stieger B
    Drug Metab Dispos; 2007 Aug; 35(8):1400-7. PubMed ID: 17496208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of modulators of the liver-specific organic anion-transporting polypeptides (OATPs) 1B1 and 1B3 from Rollinia emarginata Schlecht (Annonaceae).
    Roth M; Araya JJ; Timmermann BN; Hagenbuch B
    J Pharmacol Exp Ther; 2011 Nov; 339(2):624-32. PubMed ID: 21846839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence-based assays for the assessment of drug interaction with the human transporters OATP1B1 and OATP1B3.
    Bednarczyk D
    Anal Biochem; 2010 Oct; 405(1):50-8. PubMed ID: 20540932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3.
    Gui C; Miao Y; Thompson L; Wahlgren B; Mock M; Stieger B; Hagenbuch B
    Eur J Pharmacol; 2008 Apr; 584(1):57-65. PubMed ID: 18321482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preincubation-dependent and long-lasting inhibition of organic anion transporting polypeptide (OATP) and its impact on drug-drug interactions.
    Shitara Y; Sugiyama Y
    Pharmacol Ther; 2017 Sep; 177():67-80. PubMed ID: 28249706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-lasting inhibitory effects of saquinavir and ritonavir on OATP1B1-mediated uptake.
    Shitara Y; Takeuchi K; Horie T
    J Pharm Sci; 2013 Sep; 102(9):3427-35. PubMed ID: 23440887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organic anion transporter 3- and organic anion transporting polypeptides 1B1- and 1B3-mediated transport of catalposide.
    Jeong HU; Kwon M; Lee Y; Yoo JS; Shin DH; Song IS; Lee HS
    Drug Des Devel Ther; 2015; 9():643-53. PubMed ID: 25653502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of hepatic uptake transporters by flavonoids.
    Mandery K; Balk B; Bujok K; Schmidt I; Fromm MF; Glaeser H
    Eur J Pharm Sci; 2012 May; 46(1-2):79-85. PubMed ID: 22394605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Okadaic acid is taken-up into the cells mediated by human hepatocytes transporter OATP1B3.
    Ikema S; Takumi S; Maeda Y; Kurimoto T; Bohda S; Chigwechokha PK; Sugiyama Y; Shiozaki K; Furukawa T; Komatsu M
    Food Chem Toxicol; 2015 Sep; 83():229-36. PubMed ID: 26134461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different interaction profiles of direct-acting anti-hepatitis C virus agents with human organic anion transporting polypeptides.
    Furihata T; Matsumoto S; Fu Z; Tsubota A; Sun Y; Matsumoto S; Kobayashi K; Chiba K
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4555-64. PubMed ID: 24867984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions in Vivo.
    Durmus S; Lozano-Mena G; van Esch A; Wagenaar E; van Tellingen O; Schinkel AH
    Mol Pharm; 2015 Dec; 12(12):4259-69. PubMed ID: 26474710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.
    Kunze A; Huwyler J; Camenisch G; Poller B
    Drug Metab Dispos; 2014 Sep; 42(9):1514-21. PubMed ID: 24989890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical importance of OATP1B1 and OATP1B3 in drug-drug interactions.
    Shitara Y
    Drug Metab Pharmacokinet; 2011 Jun; 26(3):220-7. PubMed ID: 21297316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.